| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Lewis Earl is a Director at TECOGEN INC. with holdings across 2 companies. Recent SEC Form 4 filings include 8 buys and 1 sell.
Estimated insider holdings value: $7.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | TGEN Tecogen Inc. | Director | Buy | 15,000 | $1.86 | $27,900.00 | +2.9% | -20.7% | -37.0% | |
| Jun 8, 2020 | TGEN Tecogen Inc. | Director | Buy | 11,711 | $0.82 | $9,603.02 | +11.7% | - | - | |
| May 25, 2017 | HBIO Harvard Bioscience Inc | Director | Buy | 12,238 | $2.35 | $28,764.54 | +1.3% | - | - | |
| May 24, 2017 | HBIO Harvard Bioscience Inc | Director | Buy | 10,000 | $2.38 | $23,800.00 | +1.2% | - | - | |
| Dec 6, 2016 | HBIO Harvard Bioscience Inc | Director | Sell | 23,088 | $2.42 | $55,872.96 | -5.6% | - | - | |
| Dec 2, 2015 | HBIO Harvard Bioscience Inc | Director | Buy | 27,221 | $3.28 | $89,284.88 | +7.5% | - | - |